Jorge Conde

Fondateur chez Tafkak, Inc.

Profil

Jorge Conde is the founder of Tafkak, Inc. (founded in 2007) and currently holds positions as Director at Octant, Inc., Director at Aria Pharmaceuticals, Inc., Director at Tmunity Therapeutics, Inc., Director at Asimov, Inc., Director at IDRx, Inc., Partner at AH Capital Management LLC (since 2017), Board Member at Komodo Health, Inc. (since 2020), and Board Member at Dyno Therapeutics, Inc. (since 2021).
He previously served as an Independent Director at EQRx, Inc. (from 2020 to 2023) and CAMP4 Therapeutics Corp.
(from 2018 to 2024).
Prior to his current and former positions, Mr. Conde held roles as Manager-Operations & Marketing at MedImmune LLC, Investment Banker at Morgan Stanley, and Head-Business Development at Helicos Biosciences Corp.
He also served as Chief Strategy Officer at Syros Pharmaceuticals, Inc. from 2016 to 2017.
Mr. Conde received his undergraduate degree from The Johns Hopkins University, his graduate degree from Harvard Mit Health Sciences & Technology, and his MBA from Harvard Business School in 2005.

Postes actifs de Jorge Conde

Sociétés	Poste	Début
Tafkak, Inc.	Fondateur	27/04/2010
AH Capital Management LLC	Private Equity Investor	01/01/2017
Tmunity Therapeutics, Inc.	Directeur/Membre du Conseil	01/01/2019
Octant, Inc.	Directeur/Membre du Conseil	-
Dyno Therapeutics, Inc.	Directeur/Membre du Conseil	01/01/2021
Komodo Health, Inc.	Directeur/Membre du Conseil	01/01/2020
Asimov, Inc.	Directeur/Membre du Conseil	01/01/2019
IDRx, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Jorge Conde

Sociétés	Poste	Fin
CAMP4 THERAPEUTICS CORPORATION	Directeur/Membre du Conseil	10/10/2024
░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░ ░░░░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-